The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $45.01

Today's change0.00 0.00%
Updated February 22 4:01 PM EST. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $45.01

Today's change0.00 0.00%
Updated February 22 4:01 PM EST. Delayed by at least 15 minutes.

Abbott Laboratories unchanged

Abbott Laboratories closed unchanged Wednesday sitting at (U.S.)$45.01. Over the last five days, shares have gained 2.30% and are currently 1.70% off of the 52-week high. Shares have underperformed the S&P 500 by 6.51% during the last year.

Key company metrics

  • Open(U.S.) $44.88
  • Previous close(U.S.) $45.01
  • High(U.S.) $45.11
  • Low(U.S.) $44.81
  • Bid / Ask(U.S.) $42.90 / (U.S.) $45.30
  • YTD % change+17.18%
  • Volume7,534,641
  • Average volume (10-day)7,618,718
  • Average volume (1-month)9,039,028
  • Average volume (3-month)9,012,872
  • 52-week range(U.S.) $36.76 to (U.S.) $45.79
  • Beta1.43
  • Trailing P/E62.86×
  • P/E 1 year forward18.36×
  • Forward PEG1.63×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield2.36%
  • Trailing EPS(U.S.) $0.72
Updated February 22 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.58%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue5,3335,3025,3334,885
Total other revenue--------
Total revenue5,3335,3025,3334,885
Gross profit3,0213,0173,0522,746
Total cost of revenue2,3122,2852,2812,139
Total operating expense4,3854,4054,5174,361
Selling / general / administrative1,6091,6181,7461,683
Research & development343352348379
Depreciation / amortization121140145144
Interest expense (income), net operating--------
Unusual expense (income)--10-316
Other operating expenses, total--------
Operating income948897816524
Interest income (expense), net non-operating-129-117-103-58
Gain (loss) on sale of assets--------
Other--------
Income before tax875-1797152
Income after tax765-35759956
Income tax, total110178116-54
Net income798-329615316
Total adjustments to net income--------
Net income before extra. items765-35759956
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items765-35759956
Inc. avail. to common incl. extra. items798-329615316
Diluted net income798-329615316
Dilution adjustment--000
Diluted weighted average shares1,4831,4761,4801,484
Diluted EPS excluding extraordinary itemsvalue per share0.52-0.240.400.04
Dividends per sharevalue per share0.260.260.260.26
Diluted normalized EPSvalue per share0.52-0.240.400.04